Display options
Share it on
Full text links
Springer

Clin Pharmacokinet. 1994 Mar;26(3):161-8. doi: 10.2165/00003088-199426030-00001.

Pharmacokinetic considerations in rational drug design.

Clinical pharmacokinetics

M Gumbleton, W Sneader

Affiliations

  1. Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow, Scotland.

PMID: 8194280 DOI: 10.2165/00003088-199426030-00001

[No abstract available.]

References

  1. Acta Psychiatr Scand. 1986 Jan;73(1):17-21 - PubMed
  2. Drugs. 1985 May;29(5):455-73 - PubMed
  3. Mol Pharmacol. 1993 Feb;43(2):191-9 - PubMed
  4. Pharm Res. 1992 Dec;9(12):1592-8 - PubMed
  5. Chemotherapy. 1969;14(4):195-226 - PubMed
  6. Mol Pharmacol. 1986 Oct;30(4):345-51 - PubMed
  7. Pharm Res. 1990 Aug;7(8):879-83 - PubMed
  8. Arzneimittelforschung. 1978;28(5):824-7 - PubMed
  9. Antimicrob Agents Chemother (Bethesda). 1964;10:554-61 - PubMed
  10. Pharm Res. 1991 Dec;8(12 ):1453-60 - PubMed
  11. Antimicrob Agents Chemother. 1985 Oct;28(4):504-7 - PubMed
  12. Clin Pharmacol Ther. 1992 Sep;52(3):297-306 - PubMed
  13. Experientia. 1969 Sep 15;25(9):899-901 - PubMed
  14. Antimicrob Agents Chemother. 1984 Jan;25(1):78-82 - PubMed
  15. Eur J Clin Pharmacol. 1981;20(4):283-92 - PubMed
  16. J Pharm Sci. 1986 Nov;75(11):1028-40 - PubMed
  17. J Pharmacokinet Biopharm. 1989 Aug;17(4):509-21; discussion 521-3 - PubMed
  18. Drug Metab Rev. 1991;23(3-4):355-73 - PubMed
  19. Scand J Gastroenterol Suppl. 1985;108:79-94 - PubMed
  20. Xenobiotica. 1992 Jul;22(7):743-55 - PubMed
  21. Mutat Res. 1992 Sep;277(3):251-75 - PubMed
  22. J Pharm Pharmacol. 1957 Jun;9(6):345-80 - PubMed

MeSH terms

Publication Types

LinkOut - more resources